SKNY Pharmaceuticals

United States
Delaware, Ohio, United States

Company profile

SKNY Pharmaceuticals company profile

SKNY Pharmaceuticals is a privately held pharmaceutical business that specializes in innovative therapeutics that address weight reduction and smoking cessation by altering cannabinoid receptors CB1 and CB2, which are implicated in appetite, metabolism, energy balance, and nicotine dependence.

Business identity

Operating status
Active
Company type
For Profit

Headquarters

Headquarters
Delaware, Ohio, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Articles
16
Exited on
2025-03-19

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.